|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
1 April 2013 |
|
Main ID: |
NCT01072513 |
|
Date of registration:
|
19/02/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Semen Analysis After Proton Therapy for Prostate Cancer
PR08 |
|
Scientific title:
|
Semen Analysis Following Definitive Treatment of Prostate Cancer With Proton Radiation Therapy Alone |
|
Date of first enrolment:
|
March 2010 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01072513 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention Model: Single Group Assignment, Masking: Open Label
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Intake Coordinator |
|
Address:
|
|
|
Telephone:
|
877-686-6009 |
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Intake Coordinator |
|
Address:
|
|
|
Telephone:
|
(877) 686-6009 |
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Bradford S Hoppe, MD, MPH |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Florida Proton Therapy Institute |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosis of low to intermediate risk prostate cancer and elected to have proton
radiation therapy at University of Florida Proton Therapy Institute (UFPTI).
Exclusion Criteria:
- Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo.
- History of vasectomy.
- Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin.
- Current use of Avodart or Proscar.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Prostate Cancer
|
|
Intervention(s)
|
|
Other: Semen analysis
|
|
Primary Outcome(s)
|
|
Post treatment sperm count
[Time Frame: 12 months after radiation therapy]
|
|
Secondary Outcome(s)
|
|
Compare changes in sperm motility, sperm morphology and semen PH.
[Time Frame: 12 months after radiation therapy]
|
|
Secondary ID(s)
|
|
UFPTI-0908-PR08
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|